论文部分内容阅读
目的:推荐一种临床用于治疗气虚血瘀型中风后遗症的药物。方法:临床患者治疗前后神经功能积分值的比较,患者治疗前后血液流变学指标的改变观察。结果:扶正通络组治疗前后比值<0.01,中成药对照组治疗前后比值<0.05。扶正通络胶囊对气虚血瘀型中风后遗症患者的全血粘度(MPAS)、高切120s-1、低切10s-1、血浆高切120s-1和全血还原粘度均有明显改善,P<0.01,差异极其显著。结论:扶正通络胶囊治疗气虚血瘀型缺血性中风后遗症有着很好的治疗效果。
Objective: To recommend a clinical drug for the treatment of qi deficiency and blood stasis type sequelae. Methods: Comparison of neurological function scores before and after treatment in clinical patients, changes in blood rheology parameters before and after treatment. Results: The ratio of Fuzheng Tongluo group before and after treatment was less than 0.01, and the ratio before and after treatment of Chinese traditional medicine control group was less than 0.05. Fuzheng Tongluo Capsule significantly improved the whole blood viscosity (MPAS), high cut 120s-1, low cut 10s-1, plasma high cut 120s-1 and whole blood reduced viscosity of patients with qi deficiency and blood stasis type sequelae after stroke. P< 0.01, the difference is extremely significant. Conclusion: Fuzheng Tongluo capsule has a good therapeutic effect in the treatment of qi deficiency and blood stasis type ischemic stroke sequelae.